AL

Healthcare · Pharmaceuticals

Albert David Ltd (ALBERTDAVD)

₹762.60

Mkt cap
₹445 Cr
P/E ratio
15.50
P/B
1.03
Div yield
0.64%
ROE
−0.44%
ROCE
0.82%
EPS (TTM)
₹49.20
Book value
₹739
52W range
580–932
Sector
Healthcare

Price history

Previous close

Incorporated in 1938, Albert David Ltd is in the business of manufacturing pharmaceutical products [1]

NSE ALBERTDAVDBSE 524075
Health check
Cautious
ValuationCheap
ProfitabilityWeak
GrowthLow
TechnicalsNeutral
52-week range
−18.16% from high
₹763
₹580+31.51% from low₹932
Current
₹762.60
Prev close
₹755.35
Day
+0.96%
Price performance
1D
+1.81%
1W
−2.04%
1M
−1.95%
3M
−10.91%
6M
+8.88%
1Y
−5.49%
YTD
+1.32%

Financials

Revenue, profit & margin
P/E ratio
15.5×
ALBERTDAVD is 54% below the sector median of 33.4×
ALBERTDAVD15.5×
Sector median33.4×
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales93.1888.2889.0689.3698.4483.0874.8970.5787.2489.9385.86101.34100.83
YoY Sales growth+0.87%+18.39%+9.38%-2.82%+5.64%-5.89%-15.91%-21.03%-11.38%+8.25%+14.65%+43.60%+15.58%
Expenses77.2179.9279.4988.4892.2282.4079.6481.2384.7079.1083.1090.7089.18
Operating Profit15.978.369.570.886.220.68-4.75-10.662.5410.832.7610.6411.65
OPM %17.14%9.47%10.75%0.98%6.32%0.82%-6.34%-15.11%2.91%12.04%3.21%10.50%11.55%
Other Income12.1016.8810.4423.0620.64-9.01-5.1122.04-2.1412.40-24.8427.96-3.64
Interest0.060.120.070.090.060.130.130.550.750.900.430.520.40
Depreciation1.461.681.831.791.671.701.822.392.232.422.722.292.52
Profit before tax26.5523.4418.1122.0625.13-10.16-11.818.44-2.5819.91-25.2335.795.09
Tax %23.54%20.14%28.77%14.60%28.09%-7.68%-12.53%5.92%27.91%23.10%-15.06%10.62%43.42%
Net Profit20.3018.7212.9118.8418.07-9.39-10.337.94-3.3015.30-21.4332.002.88
EPS in Rs35.5732.8022.6233.0131.66-16.45-18.1013.91-5.7826.81-37.5556.075.05
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move +1.14% · closed higher next day 1 of last 2
 Q1FY27Q2FY27
Broadcast6 Aug '2612 Nov '26
Earnings day+5.45%−3.17%
+1 day+18.77%−3.66%
+5 days+15.78%−7.30%
+15 days+28.50%—
+30 days+20.32%—
FilingXBRLXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
62.23%Promoter
Promoters62.23%
FIIs0.60%0.03
DIIs1.63%
Public35.53%0.03
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,867.5036.424,48,0760.86%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹11,080.0086.072,94,1390.27%1,127+63.57%3,676+35.40%21.97%
Torrent Pharma.₹4,691.2082.191,78,4380.81%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,220.0089.521,19,9490.09%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,192.0026.241,18,9020.08%928−27.96%7,910+29.17%21.14%
Dr Reddy's Labs₹1,377.9041.111,15,0920.58%913−31.35%8,698−1.48%13.04%
Cipla₹1,394.5036.281,12,6600.93%852−35.05%7,404−2.44%15.49%
Albert David₹778.9015.474450.64%3+187.27%101+15.58%0.82%
Median: 160 Co.₹449.5033.402,0180.08%13+33.73%179+21.23%14.94%

Filings